Denmark - 5.5M people, single gene pool
Germany - 81M people
France - 65M USA - 311M I can't find the cite right now, but I know that in the last 10 years we've more than doubled public/private spend on medical research, that's a 7%/year increase. And in 2000 I think the US was spending more on medical research than the next 15 countries combined. So, I would, as usual, suggest two things. One - what works for small countries and companies does not always (or even often) work for large ones. Two - There is significant "free ridership" in the global healthcare market. Finally, ask yourself one simple question: if you get really really really sick with something serious you get on your G5 and fly to..... where? _XC PS - Not saying we are perfect, but baby/bathwater and all that.
It seems the me much of the private spend in centered in replacing drugs that treat chronic illness before they reach public domain. (not exactly a public good). solution to the "large country problem" -> federalism. 311 / 50 = 6.2 million well within reach. solution to the "heterogeneity problem" -> white folks need to stop pretending that being white is a genetically meaningful thing. (Seriously is there genetically meaningful way to include Italians, Greeks, Poles and the Irish in one group and exclude Mexicans, Jews and North Africans from that group? ) for your last question Canada is the answer and I would drive.
unless it could be cured pharmacologically in which case I would head south.